Amit Gupta - Oct 1, 2024 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role
Chief Executive Officer, Director
Signature
/s/ Nick Lynton, Attorney-in-Fact
Stock symbol
CDLX
Transactions as of
Oct 1, 2024
Transactions value $
-$23,270
Form type
4
Date filed
10/3/2024, 07:06 AM
Previous filing
Aug 22, 2024
Next filing
Oct 24, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDLX Common Stock Options Exercise +14.4K +9.53% 165K Oct 1, 2024 Direct F1
transaction CDLX Common Stock Sale -$23.3K -7.54K -4.57% $3.09 157K Oct 2, 2024 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDLX Restricted Stock Units Options Exercise $0 -14.4K -14.29% $0.00 86.1K Oct 1, 2024 Common Stock 14.4K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.
F2 Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on October 1, 2024. The Reporting Person did not sell shares for any other purpose.
F3 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $3.05 to $3.145, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).
F4 The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date.